Welcome to Mælandsmo's Group
The research group is studying biological and therapeutic aspects of the metastatic process, the principle cause of death in cancer patients. Our goal is to extend the knowledge about how the individual steps in this complicated process are regulated, and subsequently use this information for identification of potential target molecules that can be utilized in cancer therapy.
Professor Gunhild M. Mælandsmo, who is the administrative group leader.
The group is member of the Center for Research Based Innovation, Cancer Stem Cell Innovation Center (CAST)., and the K.G. Jebsen centre for Breast Cancer Research http://www.med.uio.no/klinmed/forskning/sentre/kgj-brystkreftforskning/om/kontakt/.
Contact information
The Norwegian Radium Hospital, Montebello, 0310 Oslo, Norway
Phone: +47 22 78 18 79(Mælandsmo) +47 22 78 12 68(Dept. secretary), Fax: +47 22 78 17 95
Email: gunhildm@rr-research.no
Landscape of cancer genes and mutational processes in breast cancer
May 21, 2012
Latest publications
Metastasis: biology and therapy group
Erratum to: Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients
Tumour Biol (in press)
PubMed 22562266
Effect of antiangiogenic therapy on tumor growth, vasculature and kinase activity in basal- and luminal-like breast cancer xenografts
Mol Oncol (in press)
PubMed 22521242
B7-H3 expression in colorectal cancer: Nuclear localization strongly predicts poor outcome in colon cancer
Int J Cancer (in press)
PubMed 22473715
More publications





Print this page
